Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.

about

Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.

Item

http://www.wikidata.org/entity/Q36146337

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@ast

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@en

type

Item

label

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@ast

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@en

prefLabel

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@ast

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@en

P1476

Dasatinib enhances tumor growt ...... pic bladder cancer xenografts.

@en

P2093

Axel Haferkamp

http://www.w3.org/2001/XMLSchema#string

Felix Wezel

http://www.w3.org/2001/XMLSchema#string

Florian Rothweiler

http://www.w3.org/2001/XMLSchema#string

Hans-Michael Kvasnicka

http://www.w3.org/2001/XMLSchema#string

Jindrich Cinatl

http://www.w3.org/2001/XMLSchema#string

Kilian M Gust

http://www.w3.org/2001/XMLSchema#string

Maximilian P Brandt

http://www.w3.org/2001/XMLSchema#string

Peter C Black

http://www.w3.org/2001/XMLSchema#string

Roman A Blaheta

http://www.w3.org/2001/XMLSchema#string

Stefan Vallo

http://www.w3.org/2001/XMLSchema#string

P2860

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy"

Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12

Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.

Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.

Role of Src expression and activation in human cancer.

Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations.

Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.

P2888

s13104-016-2256-3

P304

454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13104-016-2256-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Michaelis

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005111510

http://www.w3.org/2001/XMLSchema#string

P698

27677700

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5039786

http://www.w3.org/2001/XMLSchema#string